- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06269354
Multi-center Study on Comprehensive Diagnosis and Treatment of Lower Limb Bone Defect Based on Three-dimensional Printing Technology
February 20, 2024 updated by: Peking University Third Hospital
The clinical diagnosis and treatment of lower limb bone defect is a difficult problem in orthopedics.
The traditional treatment has the shortcomings of long treatment period, no weight bearing in the early stage of the limb, weak mechanical strength, many complications, and difficulty in repairing deformed and large segment bone defects around the joint.
The Orthopedics Department of Peking University Third Hospital, the lead unit of this study, developed the TCBridge system based on three-dimensional (3D) printing technology in the early stage, which is the first approved 3D printing lower limb long bone defect repair system in China.
The system can achieve personalized and accurate repair of lower limb bone defects, and ensure patients to carry out limb weight and functional exercise safely in the early stage after surgery.
On this basis, this study will establish a multi-center clinical case cohort to achieve accurate comprehensive diagnosis and treatment of lower limb bone defects, benefiting patients and contributing to society.
Study Overview
Study Type
Observational
Enrollment (Estimated)
120
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Bingchuan Liu, Doctor
- Phone Number: +86 18310188678
- Email: liubc@bjmu.edu.cn
Study Locations
-
-
Haidian
-
Beijing, Haidian, China
- Recruiting
- Peking University Third Hospital
-
Contact:
- Bingchuan Liu
- Phone Number: +86 18310188678
- Email: liubc@bjmu.edu.cn
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Patients with lower limb defects
Description
Inclusion Criteria:
- Patients with traumatic lower limb bone defect;
- Infected lower limb bone defect patients;
- Patients with neoplastic lower limb bone defect;
- The above reasons caused bone defects of more than 5CM
- at least 18 years of age;
- Sign an informed agreement and join the study cohort voluntarily.
Exclusion Criteria:
- Patients who do not agree to the use of 3D printed microporous titanium alloy prostheses;
- Patients who cannot tolerate surgery;
- the subjects cannot comply with the follow-up or affect the scientific and integrity of the study;
- Other patients who were not suitable for inclusion as assessed by clinicians.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Traumatic bone defect in lower limb
|
3D printed prostheses
|
|
Infective lower limb bone defect
|
3D printed prostheses
|
|
Neoplastic bone defect in lower limb
|
3D printed prostheses
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Evaluation of implant stability, new bone growth- limb length
Time Frame: post-operative 1.3.6.12.24.36 months
|
X-ray X、CT images
|
post-operative 1.3.6.12.24.36 months
|
|
Evaluation of bone healing
Time Frame: post-operative 3.6.12.24.36 months
|
computed tomography (CT)
|
post-operative 3.6.12.24.36 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pain assessment
Time Frame: post-operative 1.3.6.12.24.36 months
|
Visual Analog Score (VAS), total score is 10, "0" represents no pain, "10" represents the most unbearable pain
|
post-operative 1.3.6.12.24.36 months
|
|
Evaluation of life quality and health status.
Time Frame: post-operative 1.3.6.12.24.36 months
|
36-item short form survery (SF-36) questionnaire, it includes 8 itmem, namely physical functioning, vitality, bodily pain, general health, social functioning, role physical, role emotional, mental health.
The maximum score of each item is 100, higher score represents better result.
|
post-operative 1.3.6.12.24.36 months
|
|
Evaluation of knee function
Time Frame: post-operative 1.3.6.12.24.36 months
|
hospital for special surgery (HSS) score.
The maximum score of HSS is 100, higher score represents better result.
|
post-operative 1.3.6.12.24.36 months
|
|
Evaluation of hip function
Time Frame: post-operative 1.3.6.12.24.36 months
|
Harris score, The maximum score of Harris score is 100, higher score represents better result.
|
post-operative 1.3.6.12.24.36 months
|
|
Evaluation of ankle function
Time Frame: post-operative 1.3.6.12.24.36 months
|
American Orthopaedic Foot & Ankle Society (AOFAS) score,The maximum score of AOFAS score is 100, higher score represents better result.
|
post-operative 1.3.6.12.24.36 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 1, 2023
Primary Completion (Estimated)
June 1, 2026
Study Completion (Estimated)
December 31, 2026
Study Registration Dates
First Submitted
December 18, 2023
First Submitted That Met QC Criteria
February 20, 2024
First Posted (Estimated)
February 21, 2024
Study Record Updates
Last Update Posted (Estimated)
February 21, 2024
Last Update Submitted That Met QC Criteria
February 20, 2024
Last Verified
November 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- 20231121-71479
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Bone Defects
-
BioceramedUniversidade Nova de LisboaTerminated
-
TC Erciyes UniversityCompleted
-
A.A. Partners, LLCUnknown
-
Omar SaadCompleted
-
Al-Azhar UniversityNot yet recruitingPeriodontal Bone Defects
-
Peking University Third HospitalUnknownLarge Bone DefectsChina
-
Cairo UniversityCompletedOsteomyelitis Chronic | Bone DefectsEgypt
-
BioceramedCompletedBone Defects | Dental AreaBelgium
-
The University of Texas Medical Branch, GalvestonUnited States Department of DefenseCompletedSegmental Long Bone DefectsUnited States
Clinical Trials on 3D printed prostheses
-
Moataz Sleem Ahmed AliNot yet recruiting
-
Alexandria UniversityCompletedOrthodontic Bracket PlacementEgypt
-
Hospital Universitario 12 de OctubreRecruitingNon Invasive Ventilation | Ventilatory Failure | COPD, Severe Early-Onset | AlsSpain
-
University of CincinnatiEnrolling by invitationMandible Fracture | Maxillofacial TraumaUnited States
-
Thorsten GruenheidCompleted
-
The Affiliated Hospital of Putian UniversityCompletedThoracolumbar; Spina Bifida
-
Florida International UniversityCompletedChronic Disease
-
Indonesia UniversityCompletedMandibular Reconstruction | 3d Printing | Facial Symmetry | Free Fibular Flap | 3d ModelIndonesia
-
Creighton UniversityRecruiting
-
VA Office of Research and DevelopmentCompletedDiabetesUnited States